Glucothera

Glucothera is an injectable electrolyte solution containing sodium lactate, magnesium chloride, sodium chloride, and calcium chloride. The formulation is supplied as a sterile solution for injection, with the specific concentration not disclosed. Designed for use in clinical settings, Glucothera provides a source of key electrolytes and fluid volume to help maintain plasma osmolarity and electrolyte balance. It is marketed in the European Union pharmaceutical market.

Glucothera is indicated for clinical situations that require rapid fluid and electrolyte replacement, particularly when patients are unable to maintain adequate intravascular volume through oral intake.

- Fluid resuscitation in hypovolemic patients to quickly restore circulating blood volume. - Electrolyte replacement for metabolic disturbances such as hyponatremia or hypomagnesemia. - Support of parenteral nutrition regimens by providing essential sodium, calcium, and magnesium ions. - Management of postoperative fluid losses through continuous infusion to maintain hemodynamic stability. - Treatment of dehydration due to gastrointestinal losses, including vomiting or diarrhea, with balanced electrolyte composition. - Use during dialysis to replenish electrolytes lost during the treatment process.

Adverse reactions to Glucothera are generally related to its electrolyte composition and route of administration.

Common: - Injection site pain, erythema, or mild swelling. - Transient increase in serum sodium concentration. - Mild metabolic alkalosis due to lactate metabolism. - Slight elevation of serum magnesium levels without clinical symptoms.

Serious: - Severe electrolyte imbalance such as hypernatremia, hypermagnesemia, or hypercalcemia. - Anaphylactic or severe hypersensitivity reaction. - Cardiac arrhythmias caused by rapid shifts in electrolyte concentrations. - Pulmonary edema or fluid overload in patients with compromised cardiac function.

When using Glucothera, clinicians should consider several safety factors to minimize risk.

- Obtain baseline serum electrolyte and renal function tests before initiating therapy. - Monitor serum electrolytes and fluid balance regularly during infusion. - Adjust infusion rate in patients with cardiac or renal impairment to avoid overload. - Avoid administration in individuals with known hypersensitivity to any component of the solution. - Use caution in pregnant or lactating women until safety data are available. - Evaluate total fluid input to prevent pulmonary edema in at‑risk patients. - Ensure compatibility with the infusion set and avoid mixing with incompatible solutions.

Glucothera may interact with other agents that affect electrolyte balance or fluid status.

Avoid: - Concurrent infusion of high‑dose sodium bicarbonate solutions. - Co‑administration with calcium‑containing parenterals without compatibility testing. - Simultaneous use of hypertonic saline solutions.

Use with caution: - Concomitant use of loop or thiazide diuretics. - Concurrent therapy with ACE inhibitors, ARBs, or other renin‑angiotensin system blockers. - Administration alongside cardiac glycosides such as digoxin.